Ziegler Capital Management, LLC Sage Therapeutics, Inc. Transaction History

Ziegler Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$27.52 - $37.99 $339,211 - $468,264	-12,326 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$30.71 - $45.71 $32,552 - $48,452	-1,060 Reduced 7.92%	12,326 $408,000
Q4 2021 Feb 09, 2022	SELL	$37.06 - $47.11 $173,144 - $220,097	-4,672 Reduced 25.87%	13,386 $569,000
Q3 2021 Oct 27, 2021	BUY	$40.26 - $57.37 $217,524 - $309,970	5,403 Added 42.69%	18,058 $800,000
Q2 2021 Jul 21, 2021	BUY	$54.88 - $79.29 $694,506 - $1 Million	12,655 New	12,655 $719,000

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.